In a groundbreaking advancement in colorectal cancer research, scientists have uncovered a novel molecular interaction that significantly influences tumor progression. The study delves into the intricate role of a circular RNA, designated circ_0000847, revealing its powerful ability to promote cancer cell migration, invasion, and epithelial-mesenchymal transition (EMT)—critical steps in the metastasis cascade. This insight sheds light on potential new therapeutic targets for managing colorectal cancer, one of the leading causes of cancer-related mortality worldwide.
Colorectal cancer’s complex biology has long challenged scientists seeking to unravel the mechanisms behind its aggressive behavior. Recent years have brought increasing attention to non-coding RNAs, especially circular RNAs (circRNAs), which are covalently closed RNA loops exhibiting remarkable stability and diverse regulatory functions. Unlike linear RNAs, circRNAs escape exonuclease degradation due to their closed-loop structure, sustaining persistent cellular effects. Within this context, circ_0000847 emerges as a compelling player modulating gene expression through interaction with RNA-binding proteins.
The core of this study focuses on the interaction between circ_0000847 and the insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), a key RNA-binding protein implicated in mRNA stabilization and translational control. IGF2BP2 has garnered significant attention for its role in oncogenesis by stabilizing mRNAs of oncogenes and promoting their expression. By binding to IGF2BP2, circ_0000847 enhances the stability of insulin-like growth factor 2 (IGF2) mRNA, thereby amplifying its expression within colorectal cancer cells.
IGF2 itself is a well-recognized growth factor involved in embryonic development and cancer physiology, acting through the IGF1 receptor and related signaling pathways to promote proliferation and survival. Increased IGF2 expression correlates with poor prognosis in various cancers, including colorectal malignancies. The preservation of IGF2 mRNA stability via the circ_0000847 and IGF2BP2 axis suggests an important mechanism by which tumors may maintain elevated growth signals.
The research team employed an array of molecular biology techniques to meticulously dissect this axis. Techniques such as RNA immunoprecipitation, reporter assays, and gene knockdown experiments demonstrated that circ_0000847 primarily functions by sequestering IGF2BP2, resulting in enhanced binding affinity of this protein to IGF2 mRNA. This stabilization prevents its degradation and prolongs the presence of growth-promoting transcripts, culminating in increased protein translation.
Functional assessments in colorectal cancer cell lines further elucidated the phenotypic consequences of this interaction. Cells overexpressing circ_0000847 exhibited markedly increased migratory and invasive capabilities compared to controls. These phenotypes are hallmarks of metastatic potential, underscoring circ_0000847’s critical contribution to cancer cell dissemination beyond the primary tumor site, which remains a major challenge in colorectal cancer management.
Perhaps most strikingly, the study highlights how circ_0000847 influences the epithelial-mesenchymal transition (EMT), a biological process where polarized epithelial cells acquire mesenchymal, fibroblast-like properties conducive to migration. EMT is pivotal for cancer metastasis, facilitating detachment, invasion of surrounding tissues, and eventual seeding of distant organs. Circ_0000847’s capacity to intensify EMT was evident through enhanced expression of mesenchymal markers and concurrent repression of epithelial markers, highlighting its role in remodeling the cellular architecture toward a more aggressive phenotype.
Insights into the molecular underpinnings of circ_0000847’s function offer exciting avenues for therapeutic interventions. Targeting circRNAs is notoriously challenging due to their stability and abundance, but strategies aimed at disrupting their interaction with key RNA-binding proteins like IGF2BP2 may hold promise. Such approaches could destabilize oncogenic mRNAs and attenuate signaling pathways that drive colorectal tumor progression.
Considering the translational implications, biomarkers based on circ_0000847 expression or the circ_0000847–IGF2BP2 interaction could serve as prognostic tools, guiding clinical decisions and identifying patients at higher risk of metastasis. This bears significance as current colorectal cancer prognostication largely depends on pathological staging, which may not fully capture the molecular aggressiveness of individual tumors.
Furthermore, this study enhances our understanding of the non-coding RNA landscape in cancer biology, reinforcing the importance of RNA-protein interactions beyond classical gene regulation paradigms. The circ_0000847/IGF2BP2/IGF2 axis exemplifies how complex RNA networks orchestrate critical cellular processes that malignant cells hijack for survival and spread.
In the broader spectrum of cancer research, these findings underscore the need for deeper investigation into circRNA-mediated mechanisms. The stability and functional diversity of circRNAs position them as both compelling biological regulators and untapped therapeutic targets. As more circRNAs with oncogenic or tumor-suppressive roles are identified, personalized cancer treatment may soon incorporate modulation of these molecules.
This discovery also challenges us to rethink RNA-centric interventions in oncology. Traditional therapies have focused heavily on targeting proteins, but RNA-based therapeutics—such as antisense oligonucleotides, small interfering RNAs, and CRISPR-based editing—are rapidly evolving. CircRNAs like circ_0000847 might be susceptible to tailored RNA interference strategies that disrupt their oncogenic partnerships.
Notably, the interrogation of EMT-driven pathways via circRNA research opens potential cross-talk understandings with other metastasis mechanisms, including tumor microenvironment alterations and immune evasion. Further studies exploring how circ_0000847 and its associated network interact with these processes could reveal compounded effects or novel vulnerabilities.
The clinical relevance of this circRNA-mediated regulatory axis is amplified by colorectal cancer’s global burden, with metastatic disease being the leading cause of patient mortality. Intervening in the molecular events that facilitate early invasion and dissemination could dramatically improve outcomes for affected individuals.
In summary, Zhang and Zheng’s study presents compelling evidence that circ_0000847, through binding to IGF2BP2, acts as a critical promoter of colorectal cancer metastasis by stabilizing IGF2 mRNA and facilitating EMT. This breakthrough enhances our molecular understanding of colorectal cancer progression and opens promising pathways for therapeutic targeting and prognostic assessment.
As research into non-coding RNAs expands, circ_0000847’s role uniquely positions it at the forefront of novel cancer biology discoveries. The combination of robust molecular techniques and clinically relevant functional assays highlights the rigorous approach underpinning this advancement. Future efforts to translate these findings from bench to bedside will be crucial in combating colorectal cancer’s morbidity and mortality.
Continued exploration of circRNAs like circ_0000847 promises to redefine how we conceptualize RNA functions within oncogenic networks, perfectly illustrating the complexity and opportunity inherent in cancer molecular biology.
Subject of Research:
The role of circ_0000847 in promoting migration, invasion, and epithelial-mesenchymal transition (EMT) in colorectal cancer through interaction with IGF2BP2 to stabilize IGF2 mRNA.
Article Title:
Circ_0000847 promotes the migration, invasion, and EMT process in colorectal cancer through binding to IGF2BP2 to enhance IGF2 mRNA stability.
Article References:
Zhang, A., Zheng, Y. Circ_0000847 promotes the migration, invasion, and EMT process in colorectal cancer through binding to IGF2BP2 to enhance IGF2 mRNA stability. Med Oncol 42, 436 (2025). https://doi.org/10.1007/s12032-025-02877-0
Image Credits:
AI Generated
